A detailed history of Entropy Technologies, LP transactions in Incyte Corp stock. As of the latest transaction made, Entropy Technologies, LP holds 23,337 shares of INCY stock, worth $1.75 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
23,337
Holding current value
$1.75 Million
% of portfolio
0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$65.08 - $83.38 $1.52 Million - $1.95 Million
23,337 New
23,337 $1.61 Billion
Q2 2024

Aug 12, 2024

BUY
$51.18 - $63.75 $997,498 - $1.24 Million
19,490 Added 339.55%
25,230 $1.53 Billion
Q1 2024

May 08, 2024

BUY
$56.55 - $66.59 $324,597 - $382,226
5,740 New
5,740 $327 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.